Showing results (171-180 of 649) with videos related to

Sort By:
Pageof 65
PPAR Research|September 6, 2021
Rosiglitazone Alleviates Mechanical Allodynia of Rats with Bone Cancer Pain through the Activation of PPAR-γ to Inhibit the NF-κB/NLRP3 Inflammatory Axis in Spinal Cord NeuronsJie Fu, Baoxia Zhao, Chaobo Ni, et al.
PPAR Research|May 13, 2020
PPARs and the Development of Type 1 DiabetesLaurits J Holm, Mia Øgaard Mønsted, Martin Haupt-Jorgensen, et al.
PPAR Research|May 7, 2020
Pparg may Promote Chemosensitivity of Hypopharyngeal Squamous Cell CarcinomaMeng Lian, Jiaming Chen, Xixi Shen, et al.
PPAR Research|August 2, 2021
Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic CancerJilong Hu, Zhinan Zheng, Jia Lei, et al.
PPAR Research|October 10, 2022
Activation of PPARγ Protects Obese Mice from Acute Lung Injury by Inhibiting Endoplasmic Reticulum Stress and Promoting Mitochondrial BiogenesisYin Tang, Ke Wei, Ling Liu, et al.
PPAR Research|January 10, 2022
In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic AgentsDiana Alemán-González-Duhart, Samuel Álvarez-Almazán, Miguel Valdes, et al.
PPAR Research|January 29, 2016
Smad2/3 Upregulates the Expression of Vimentin and Affects Its Distribution in DBP-Exposed Sertoli CellsXi Zhang, Xiaogang Wang, Taixiu Liu, et al.
PPAR Research|November 6, 2014
PPAR Gamma Expression Levels during Development of Heart Failure in Patients with Coronary Artery Disease after Coronary Artery Bypass-GraftingIzabela Wojtkowska, Andrzej Tysarowski, Katarzyna Seliga, et al.
PPAR Research|November 6, 2014
The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levelsAmanda L McGuire, Nadia Urosevic, Doris T Chan, et al.
PPAR Research|April 13, 2016
Fenofibrate plus Metformin Produces Cardioprotection in a Type 2 Diabetes and Acute Myocardial Infarction ModelVíctor Hugo Oidor-Chan, Enrique Hong, Francisca Pérez-Severiano, et al.
Pageof 65